fda compound semaglutide stops compounding fda stopping compounded semaglutide FDA is moving to restrict mass-marketed compounded Seattle weight loss patients fret

Discrepancies between document lot numbers and physical lot numbers indicate either a documentation error or a supply chain integrity problem

A new product claims to deliver Tirzepatide , the powerful injection used in FDA-approved drugs like Mounjaro and Zepbound, via a painless microneedle patch

A note from our Chief Medical Officer | Gustav Lo, MD Every day were asked, Do you offer peptide therapy? The answer is yes

GLP-1 medications function by addressing two critical pathways in glucose management: They enhance the pancreass ability to produce insulin, the hormone responsible for lowering blood sugar, and reduce the release of glucose from the liver, However, their impact extends beyond mere glucose regulation